Post Authorization Safety Studies (PASS): Application of Retrospective Chart Review Methodology

被引：0
|
作者：
Stein, Dara [1 ]
Pan, Irene [1 ]
Payne, Krista A. [1 ]
机构：
[1] United BioSource Corp, Dorval, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
233
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [1] Post Authorization Safety Studies (PASS): Application of Prospective Observational Study Methodology
    Pan, Irene
    Walton, Amy
    Dieck, Gretchen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 123 - 124
  • [2] Insights from a review of publicly available information on post authorization safety studies (PASS)
    Almas, Mariana
    Hoogendoorn, Wilhelmina E.
    Sayeed, Sanowar
    Blackburn, Stella
    Bosco, Jaclyn
    Parmenter, Louise
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 638 - 638
  • [3] Experience of Joint Post-Authorization Safety Studies (PASS) through an Example
    Kurzinger, Marie-Laure
    Juhaeri, Juhaeri
    Chang, Cristina
    Auclert, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 477 - 477
  • [4] Innovation and pragmatism in retrospective chart review methodology for post-approval drug utilization studies
    Saragoussi, Delphine
    Rouleau, Alice
    Capart, Philippe
    Deveras, Claudia C.
    Brett, Neil R.
    Ognar, Raphael
    Gazay, Henry
    Payne, Krista
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 433 - 434
  • [5] Non-interventional post-authorization safety studies and post-authorization effectiveness studies for oncology drugs: A systematic review
    Zhang, Xiao
    Burcu, Mehmet
    Chen, Lei
    Bracco, Oswaldo L.
    Zhou, Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 279 - 280
  • [6] MULTI-NATIONAL RETROSPECTIVE CHART REVIEW STUDIES: LESSONS LEARNED FROM APPLICATION OF METHODOLOGY TO INTERNATIONAL EVALUATIONS OF BURDEN OF ILLNESS AND DRUG UTILIZATION AND SAFETY
    Payne, K. A.
    Stein, D.
    Stemhagen, A.
    VALUE IN HEALTH, 2013, 16 (03) : A52 - A52
  • [7] Big Multiple Sclerosis Data - A registry basis for post authorization safety studies (PASS) for multiple sclerosis
    Hillert, J.
    Trojano, M.
    Vukusic, S.
    Magyari, M.
    Butzkueven, H.
    Horakova, D.
    Hyde, R.
    Wormser, D.
    Sabido, M.
    Tomic, D.
    Lee, S.
    Losoczi, E.
    Elgott, S.
    Thalheim, C.
    Zaratin, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 761 - 762
  • [8] Design of a Multinational Post-Authorization Safety Study (PASS) of Crizotinib
    Ehrenstein, Vera
    Huang, Kui
    Kahlert, Johnny
    Bahmanyar, Shahram
    Karlsson, Par
    Lofling, Lukas
    Bezemer, Irene D.
    Kuiper, Josine G.
    Nunes, Anthony P.
    Enger, Cheryl
    Hoti, Fabian
    Juuti, Rosa
    Korhonen, Pasi
    Mo, Jingping P.
    Schachterle, Stephen
    Sorensen, Henrik T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 311 - 312
  • [9] The Opportunities and Challenges of Delivering the Quetiapine Post-Authorization Safety Studies (PASS): A Diverse Program of Work
    Brody, Robert S.
    Jefferies, Leigh
    Liu, Sherry
    Liss, Charles L.
    Damstetter, Phil
    Chen, Lei
    Tummala, Raj
    Desai, Dhaval G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 104 - 105
  • [10] RELIABILITY OF RETROSPECTIVE CHART REVIEW STUDIES
    MANNIS, MJ
    MILLER, M
    MARQUEZ, M
    ZADNIK, K
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1529 - 1529
12345